Valion Bio, Inc. (VBIO) Debt Components
- 2024-12-31: Line of Credit Facility, Interest Rate During Periodpure 12 month · 6.00%.
- 2024-09-30: Line of Credit Facility, Interest Rate During Periodpure 9 month · 6.00%.
- 2024-06-30: Line of Credit Facility, Interest Rate During Periodpure 6 month · 6.00%.
- 2024-03-31: Line of Credit Facility, Interest Rate During Periodpure 3 month · 6.00%.
Valion Bio, Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Line of Credit Facility, Interest Rate During Period pure |
|---|---|
| 2024-12-31 | 12 month · 6.00% |
| 2024-09-30 | 9 month · 6.00% |
| 2024-06-30 | 6 month · 6.00% |
| 2024-03-31 | 3 month · 6.00% |
| 2023-12-31 | 12 month · 6.00% |
| 2022-12-31 | 12 month · 6.00% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |